Ibrutinib vs Trastuzumab

## Ibrutinib vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Ibrutinib** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Ibrutinib — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Ibrutinib — Small molecule; Trastuzumab — Antibody.